Study design
This is a single-center, 1:1 observer-blinded randomized controlled, superiority trial. The main objective is to compare open C graft with arthroscopic assisted C chips graft reconstruction for scaphoid fractures with delayed/non-union.
Subjects
A total of 88 patients with scaphoid delayed/non-union are randomized to either:
- Group A – Arthroscopic assisted C chips graft reconstruction (intervention group), n=44
- Group O – Open C graft reconstruction (control group), n=44
Inclusion criteria
- Patients aged 18-68 years.
- A scaphoid fracture without healing 2-6 months since fracture (delayed union) for cases with either displacement >1mm or comminution and failed non-operative treatment.
- Scaphoid fracture without healing >6 months since fracture (non-union) regardless of displacement, comminution and if previous non-operative treatment has been tried.
- ASA 1-3.
Exclusion criteria
- Open fractures
- Associated trans-scaphoid perilunate dislocation.
- Associated fracture in the hand/upper extremity.
- Previous failed surgical treatment for scaphoid delayed/non-union.
- Stage 2 SNAC or above.
- Avascular necrosis of the proximal pole as evaluated with MRI and absence of punctate bleeding intraoperatively.
- Patients with gross humpback deformity of HLR >0.75 and/or DCA <70⁰.
- Patients unable to understand instructions in Danish, complete the rehabilitation protocol, or answering the questionnaires because of physical or cognitive impairment, as evaluated by the surgeon at the first visit.
Enrolment
All Danish citizens aged 18-68 years with scaphoid delayed/non-union referred to the hand surgy unit, Herlev and Gentofte University Hospital, will be offered participation in the study. Other hand unit departments in the Capital Region of Denmark will forward their referrals to our department for inclusion. The physician will review the medical records and assess whether the patients fulfil the inclusion/exclusion criteria. If the patient is found eligible, they will receive oral and written information of the study (Fig. 1), and the possibility to bring a bystander for the preparation consultation. The patients will be given a minimum of 24 hours deliberation period. At the preparation consultation with the primary investigator, the patient will once again receive oral and written information, and trial risks of the study, and subsequently the consent will be obtained. Patients can withdraw their consent at any time. The Helsinki Declaration will be followed[25]. The informed consent will give the primary investigator access to information about sex, age, comorbidity, trauma, time from fracture to treatment, history of smoking, occupation, hand dominance, pain, ongoing workers’ compensation, and insurance claim. Baseline range of motion, grip strength, Key-pinch strength, pain in rest and activity (VAS), and Q-DASH will be recorded (Fig 2).
Patients will undergo a clinical examination and CT scan of the wrist to describe angulation (HLR and DCA), displacement, localization of non-union, presence of cysts, and degenerative changes. All patients with involvement of the proximal pole will undergo gadolinium-enhanced MRI to clarify vascularity, but the final assessment of avascular necrosis of the proximal pole will be performed perioperatively. If punctate bleeding after tourniquet being off for at least 5 minutes of expectation cannot be visible, the patient will then be excluded from the study and will be simultaneously operated with a vascular bone graft or a salvage procedure.
The operations will be performed at the orthopedic department at Herlev and Gentofte University-Hospital, Denmark, which is the largest referral hand unit in Denmark. Annually 15-25 patients are treated for scaphoid delayed/non-union. With forwarded referrals included, we estimate a 3-year inclusion period from 01-01-2023 to 01-01-2026.
Randomization
Based on the sample size calculation, a total number of 88 patients will be allocated into two groups of equal size
- Group A – Arthroscopic assisted C chips graft reconstruction (intervention group), N=44.
- Group O – Open C graft reconstruction (control group), N=44.
The randomization is done in the outpatient clinic and the patients will be informed about the operative treatment. The randomization application, Research Electronic Data Capture (REDCap), will allocate patients in a 1:1 ratio, stratified for proximal pole fracture (yes /no), dislocation (>/< 2mm), and smoking (yes/ no). A statistician will generate a randomization sequence for RED-Cap.
Blinding
In this observer-blinded RCT, union is assessed by a blinded musculoskeletal radiologist. QDASH is a patient-reported survey, without the involvement of surgeons or research staff. Other secondary outcomes will be measured by an independent observer. The study will not be blinded to the operating theatre staff, surgeons, physiotherapists, or patients.
Interventions
All patients will be operated on by 4 highly experienced hand surgeons of same experience level. Two surgeons will perform the open technique and 2 surgeons the arthroscopic technique. The surgeons are using the technique which they are familiar with to avoid a learning curve affecting the outcomes.
Group A: Arthroscopic assisted cancellous chips graft reconstruction
Patients are awake in a supine position with the arm anesthetized as standard. The arm is attached to a wrist traction tower with vertical traction of 5-8 kg force through plastic finger trap devices. An arm tourniquet is applied. Through 3/4 and 4/5 portals using dry-arthroscopy, the radio-carpal joint is inspected for cartilage damage, synovitis, and ligament injuries. Mid-carpal radial (MCR) and mid-carpal ulnar (MCU) portals are applied to examine the non-union site. The non-union site is debrided with a shaver until healthy-looking bone with punctate bleeding. The C chips graft is harvested from the ipsilateral distal radius through a 2cm incision with a biopsy needle, using multiple biopsy probes. After arthroscopy, the wrist is taken out of traction and the non-union is reduced under the C-arm image intensifier and a 1.2 mm K-wire is inserted percutaneously, either in a retrograde or anterograde manner. The scaphoid is prepared with a drill, length is measured, and the graft is inserted with a trochar through the MCR portal. An Acutrak mini compression screw (Acumedtm, Hillsboro, USA) is inserted. The final position is confirmed under fluoroscopy. The non-union site is inspected, and spilled bone graft material is impacted in the gap. Finally, the skin is sutured, and a bandage is applied.
Group O: Open corticocancellous graft reconstruction
Patients are under General Anaesthesia with the arm anesthetized with a Regional Block Anaesthesia. A longitudinal volar incision, lateral to the flexor carpi radialis (FCR) curved distal over the scaphoid tuberosity is made. The FCR is retracted to the ulnar side and the volar capsule and ligaments are incised longitudinally to expose the scaphoid. The non-union is debrided to a healthy appearing bone. A C graft is harvested from the ipsilateral iliac crest through a 4cm incision. The cancellous graft is prepared and placed in the cavity. Under fluoroscopy, a 1.2mm K-wire is inserted in a retrograde or anterograde manner. After drilling, the length is measured and an Acutrak mini compression screw (Acumedtm, Hillsboro, USA) is inserted. The final position is confirmed under fluoroscopy. The capsule and ligaments are repaired, the skin is sutured, and the immobilizing bandage is applied.
Physiotherapy and rehabilitation
Rehabilitation will be identical between the groups. Stitches are removed 2 weeks postoperatively. Patients will be provided a thumb/wrist splint for 2 weeks, followed by application of removable orthosis for another 4 weeks allowing the beginning of light non-weight-bearing exercises. The wrist will be allowed mobilization without restrictions if union is established on a postoperative CT-scan and with the absence of scaphoid tenderness on the clinical examination. Return to work will be accepted when the union is established.
Outcome measures
Primary outcome
Time to union will be assessed with repeated CT scans in two weeks intervals from 6-16 weeks postoperative. If union is not achieved within 16 weeks, a CT scan will be made 24 weeks postoperatively. If union is not achieved at that point, the patient will be presented for another treatment modality. Union will be proclaimed and recorded when >50% bone bridging occurs on CT scan[26, 27].The Minimal clinically important differences (MCID) have not been defined. We use an arbitrary value of 3 weeks difference.
Primary functional outcome
The Quick Disability of the Arm, Shoulder, and Hand (Q-DASH) is a patient-reported survey[28, 29]. It is a subset of 11 items from the 30-item DASH questions that assess difficulties with specific tasks: 5 concerning symptoms, 4 on social function, and 1 on work function, sleep, and confidence. The score ranges from 0-100 and the higher score reflects disabilities. The MCID has been defined as 10.8 (range, 5-15) for comparable patients[30].
Secondary outcomes
Radiographic outcome Union rate will be evaluated with CT scans undertaken every second week. DCA, and HLR will be measured preoperative and at follow-up on CT scans to evaluate correction of deformity[11, 31].
Pain at rest and activity is recorded on a visual analogue scale (VAS), ranging from 0-10, with 10 reflecting the worst and 0 representing no pain in the wrist.
Donor site morbidity located to the iliac crest (Group O) and distal radius (Group A) are evaluated with VAS ranging from 0-10, with 10 reflecting the worst and 0 representing no pain in the wrist.
Range of motion (ROM) is measured in degrees with a goniometer, and recorded in arcs for flexion/extension, supination/pronation, and radial/ulnar deviation, compared to the unaffected wrist.
Grip strength is measured in kilograms with a Jamar dynamometer with the elbow will be in 90° flexion and attached to the chest compared to the unaffected[32].
Key pinch is measured in kilograms using a pinch gauge with the elbow in in 90° flexion and attached to the chest, compared to the unaffected wrist[33].
Patient satisfaction is evaluated with the following question: What is the function of your hand today, compared to before surgery? With the following answer options: (1) disaster, (2) much worse, (3) slightly worse, (4) unchanged, (5) slightly better, (6) much better, (7) recovered. Secondary, for future research perspective patients are asked: When you consider the following parameters: The activities you can carry out in daily life, your pain, your function of the hand, do you think your current situation is satisfactory? (yes/no)[34].
EQ5D-5L will be used to estimate the threshold for acceptable cost-utility ratio – the threshold for how much health care providers will pay for an extra quality-adjusted life year (QALY). The cost utility of the Arthroscopic- and open technique will be compared. Baseline and 2-year follow up scores will be compared. A cost model will be defined from patient data, clinical records, and unit costs from the Danish health care system. Length of hospital stay, discharge, pain medication usage and readmission will be recorded.
Complications and secondary surgery
We will record all complications related to the operative treatment (Tendon-, ligament-, nerve- or arterial injury, infection, complex regional pain syndrome, hematoma, or hardware failure). Reoperations, defined as revision surgery and secondary surgery due to no union will be noted.
Follow-up
All patients will be followed for 10 years. Union will be measured in 2 weeks intervals 6-16 weeks after operative treatment. Clinical outcomes and patient-reported outcomes will be measured after 1.5, 3, 6, 12, and 24 months. Online questionnaires will be sent after 5 and 10 years (Fig. 1).
Protocol violations and patient drop-out
The patients evaluated for inclusion will be reported in a consort diagram (Figure 2). The statistical analysis will be conducted on an intention-to-treat basis. Outcome scores will be analysed according to the initial study group assignment regardless of possible cross-over. If crossover does occur, a secondary per-protocol analysis will be conducted.
Patient drop-out/loss to follow up will be recorded and the reason will be noted. The patient is included in the analysis with their latest follow-up if at least a 6-week evaluation is available. Patients who undergo revision/secondary surgery will remain in the study and will be followed according to the index procedure. Their results before and after the revision procedure are included in the analysis. Protocol modifications will be communicated to all investigators, observers, and trial registries immediately.
Adverse events
The operative techniques are used routinely in our department and are considered safe, therefore interim analysis will not be conducted. At follow-up, patients will be asked about complications, and journal notes about hospital contacts related to the surgical procedure are recorded.
Statistics
Sample size calculation
The sample size calculation was performed with an expected mean time to union of 56 days and a SD of 30 days in Group A and 77 days and SD on 40 days in group B. The sample size required in each group to provide 80% power to detect a mean 3 weeks difference[13], with a type one error on 0.05, was 36 patients in each group. Considering dropouts and loss to follow up with a rate of 20% the final number of patients needed in total for this study is 88 patients.
Data analysis
Interim data analysis will not be carried out. Continuous data will be presented as mean with SD or as median with interquartile range (IQR) depending on the nature of data. Categorical data will be presented as counts with percentages. Differences in in demographic data and outcome measures between groups will be compared using Chi-square for categorical data, and Student t-test (parametric data) or Wilcoxon signed rank test (non-parametric data) for continuous data. The applied level of significance for all statistical analyses is P<0.05. The statistical analyses will be performed using SPSS version 25.0.
Data management
Data will be stored securely at the study location. Data will be collected in REDCap electronic data capture tools and EPIC hospital clinical digital journal system hosted in the Capital Region of Denmark. REDCap is a secure web-based data collection application. Identifying information about the patients will be stored in secured hospital servers. The primary investigator will have access to the trial materials and final dataset. The study is approved and monitored by the Danish Data Protection Agency (Pactius) and it will follow the General Data Protection Regulation and Data Protection Act. The anonymized results will be made available for meta-analysis and systematic reviews.